At the time an extraordinary general meeting (EGM) of members of the company had been requisitioned by disaffected shareholders seeking the removal of the existing board of directors. INTERLOCUTORY INJUNCTION   Introduction  1 On 12 September 2007 Pharmaust Limited (Pharmaust) lodged with the Australian Securities and Investments Commission (ASIC) a prospectus for a 1:1 entitlement rights issue at 3 cents per share with a view to raising $3,550,618. Again Mr Owen seems to have regarded this proposal as passing board control to the Chimaera Group. The allotments would be carried out by the underwriter.